Abstract: The present disclosure is directed to an electronic vaporizing device having a vehicle monitoring component for monitoring a plurality of performance data associated with a vehicle, analyzing the plurality of performance data to determine at least one vehicle condition, and outputting the data and/or analysis to a user of the device. The electronic vaporizing device may comprise at least one vehicle monitoring component operable to interface with a plurality of machine devices of an associated vehicle to capture a plurality of vehicle performance data associated with at least one of the plurality of machine devices, determine at least one performance condition based on at least a portion of the plurality of captured performance data, and generate a plurality of vehicle status data therefrom. The determination of the at least one performance condition and generation of the plurality of vehicle status data may be based on a plurality of performance data capture parameters.

Abstract: The present disclosure is directed to an electronic vaporizing device having an exterior protective housing configured to at least partially surround at least a portion of operable components of the electronic vaporizing device. In one embodiment, the exterior protective housing may include at least one light-transmitting portion. In another embodiment, the at least one light-transmitting portion may be substantially transparent, at least partially transparent, and/or translucent. In an embodiment, the at least one light-transmitting portion is configured so that at least a portion of the operable components of the electronic vaporizing device are at least partially visible from the outside of the device during operation thereof.

Abstract: The present disclosure is directed to an electronic vaporizing device for vaporizing water-based compositions and other vaporizable materials. The electronic vaporizing device may comprise a vaporizing component having an ultrasonic vibration element operable to produce ultrasonic vibrations to vaporize at least a portion of the vaporizable material received therein. In one embodiment, the vaporizing component may further comprise a heating element operable to produce heat energy to vaporize at least a portion of the vaporizable material received therein. In one embodiment, the electronic vaporizing device may comprise a processor operable to generate at least one vaporizing control signal for selectively operating at least one of the ultrasonic vibration element and the heating element. The operation of the vaporizing component may be determined by an associated user, by a third party via a remote device, and the like.

Abstract: An electronic vaporizing device comprising at least one power source for power generation for operation of the device, wherein at least a portion of the power generated thereby may be provided to at least one other electronic device that may be connected or associated with the electronic vaporizing device. The electronic vaporizing device may include a power output control component that regulates the power provided to the vaporizing device and to the at least one other electronic device. A method is also provided for the provisioning of power generated by a power source of an electronic vaporizing device.

Abstract: A system and method for subscriber aware network monitoring is provided. The method includes: determining subscriber and session data, wherein the subscriber has a non-unique IP (Internet Protocol) address; retrieving identifying data from a packet; and comparing the identifying data with the determined subscriber and session data to determine the subscriber associated with the packet. The system includes: at least one network probe configured to determine subscriber and session data, wherein the subscriber has a non-unique Internet Protocol (IP) address; at least one traffic probe configured to retrieve identifying data from a packet; and a processing module configured to compare the identifying data with the stored subscriber and session data to determine the subscriber associated with the packet.

Abstract: The present invention relates to imidazopyridazine derivatives. More particularly, it relates to 4-(biphenyl-3-yl)-7H-imidazo[4,5-c]pyridazine derivatives of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined in the description. The imidazopyridazine derivatives of the present invention modulate the activity of the GABAA receptor.

Abstract: A method of manufacturing an article by hot pressing and ultrasonically inspecting the article comprises forming and filling a canister with powder material and evacuating and sealing the canister. Heat and pressure are applied to the canister to consolidate the powder material to form the article. The article within the canister is ultrasonically inspected by moving a transducer over the whole of the canister. The position of an interface between the article and the canister, and the thickness of the canister, at each position on the surface of the canister and if there are defects within the article are determined. The canister is then removed from the article by machining the canister using a machining tool, the movement of the tool is controlled such that at each position of the canister the tool removes the determined thickness of the canister for the corresponding position on the surface of the canister.

Abstract: A patient interface for delivering breathable gas to a patient includes a nasal prong assembly including a pair of nasal prongs structured to sealingly communicate with nasal passages of a patient's nose in use and headgear to maintain the nasal prong assembly in a desired position on the patient's face. The headgear includes side straps and rigidizers provided to respective side straps. Each rigidizer includes a first end portion that provides a connector structured to engage a respective end of the nasal prong assembly and an inwardly curved protrusion in the form of a cheek support that curves inwardly of the connector. The cheek support is adapted to follow the contour of the patient's cheek and guide a respective end portion of the side strap into engagement with the patient's cheek to provide a stable cheek support.

Abstract: CHO cell-specific synthetic promoter constructs for expressing recombinant proteins, a library of promoter constructs thereof, and a method for producing the promoter constructs. The promoter constructs enable precise control of recombinant gene transcription over three orders of magnitude, with the top expressing promoters capable of double the transcriptional activity of the CMV promoter.

Abstract: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.

Abstract: A patient interface for delivering breathable gas to a patient includes a nasal prong assembly including a pair of nasal prongs structured to sealingly communicate with nasal passages of a patient's nose in use and headgear to maintain the nasal prong assembly in a desired position on the patient's face. The headgear includes side straps and rigidizers provided to respective side straps. Each rigidizer includes a first end portion that provides a connector structured to engage a respective end of the nasal prong assembly and an inwardly curved protrusion in the form of a cheek support that curves inwardly of the connector. The cheek support is adapted to follow the contour of the patient's cheek and guide a respective end portion of the side strap into engagement with the patient's cheek to provide a stable cheek support.

Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.

Abstract: Techniques are disclosed to transmit arbitrarily large data units for transaction processing in a networked environment. A request is received to store a data unit of a size exceeding an allocated memory address space of a transaction gateway component of the networked environment. A predefined store function, provided by a repository interface component, is invoked to store the data unit to a data repository component of the networked environment and without segmenting the data unit. A repository handle of the stored data unit is identified. A predefined load function, provided by the repository interface component, is invoked to load a portion of the stored data unit, based on the identified repository handle, where the portion is smaller than the stored data unit.

Abstract: Techniques are disclosed to transmit arbitrarily large data units for transaction processing in a networked environment. A request is received to store a data unit of a size exceeding an allocated memory address space of a transaction gateway component of the networked environment. A predefined store function, provided by a repository interface component, is invoked to store the data unit to a data repository component of the networked environment and without segmenting the data unit. A repository handle of the stored data unit is identified. A predefined load function, provided by the repository interface component, is invoked to load a portion of the stored data unit, based on the identified repository handle, where the portion is smaller than the stored data unit.

Abstract: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.

Abstract: A system and method for subscriber aware network monitoring is provided. The method includes: determining subscriber and session data, wherein the subscriber has a non-unique IP (Internet Protocol) address; retrieving identifying data from a packet; and comparing the identifying data with the determined subscriber and session data to determine the subscriber associated with the packet. The system includes: at least one network probe configured to determine subscriber and session data, wherein the subscriber has a non-unique Internet Protocol (IP) address; at least one traffic probe configured to retrieve identifying data from a packet; and a processing module configured to compare the identifying data with the stored subscriber and session data to determine the subscriber associated with the packet.

Abstract: Exemplary embodiments of the invention can provide computer-based systems and methods for exploring collections of documents through visual navigation. Data in a document collection can be more easily understood and explored when presented visually in infographic summaries. By interacting directly with these infographic summaries, a user can more intuitively sift through a collection to organize and locate documents based their properties, metadata, and textual information. Infographic summaries can be updated dynamically as a user selects infographic elements that automatically create document filters and redefine the current scope of displayed documents. User interactions with infographic summaries can be saved and run automatically against newly added documents, thereby classifying new documents without the need of further user interactions.

Abstract: The present disclosure relates to a method of preparing exonuclease resistant molecules of block-decoys, use of the molecules in methods of modulating expression of recombinant proteins, particularly in vitro, for example by down regulation or inhibition of one or more transcription factors, and novel molecules of block-decoys, especially those obtained or obtainable from the methods herein. The disclosure also relates to use of said block decoys in vitro and in therapy. In one aspect there is provided a method for regulating recombinant gene expression in vitro comprising the steps of: a) providing a host cell encoding one or more recombinant genes for expression, b) contacting the cell with a exonuclease resistant block-decoy under condition suitable for the block-decoy to gain entry into the cell, and c) expressing the recombinant protein or protein.

Abstract: A method including the steps of: defining an original parent polygon representative domain of interest, an origin corresponding to a wavesource position within the parent, a wavesource wavefront geometry, and a maximum wavefront extent; determining one or more valid parent polygon sides; defining cutting lines from the vertices of each valid parent side to the extent; reflecting the parent about the respective valid side defining a child polygon; discarding portions of each child polygon lying beyond a cutting line from the respective parent side; redefining each child as a parent, and repeating the second to fifth steps for each parent filling the area within the extent; projecting onto the polygons within the extent, a wavefront having the wavefront geometry spaced from the origin by a specified distance; and reflecting the child polygons along the respective sides of their respective parents projecting the child polygons and wavefront onto the original parent.

Abstract: Determining magnitude of a field variable of an energy wave through domain of interest, including steps of: defining plurality of master-particles spaced within domain, master-particles being representative of field variables of energy wave at location of respective master-particle, and defining supporting domain ?m for each master-particle; computing field variables including position, magnitude and direction of propagation of each master-particle at predetermined time; defining plurality of virtual-particles within domain representative of magnitude of field variable of wave at location of respective virtual-particle; calculating magnitude uv of field variable of each virtual-particle at time of interest by applying formula: u v = ? m = 1 N ? ? u m ? f ? ( q ? ? 1 ) × g ? ( q ? ? 2 ) Where ? ? v ? ? ? m where N is total number of master-particles, um is magnitude of respective master-particle, f(q1) is an envelope function relating magnitude of virtua